Shopping Cart
Remove All
Your shopping cart is currently empty
Topoisomerase I (Compound ZML-14) inhibitor 3 induces HepG2 cell apoptosis and arrests cell cycle at G2/M phase. Topoisomerase I inhibitor 3 is an inhibitor of topoisomerase I that interact with topoisomerase I-DNA complex [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Topoisomerase I (Compound ZML-14) inhibitor 3 induces HepG2 cell apoptosis and arrests cell cycle at G2/M phase. Topoisomerase I inhibitor 3 is an inhibitor of topoisomerase I that interact with topoisomerase I-DNA complex [1]. |
| In vitro | Topoisomerase I inhibitor 3 (Compound ZML-14) exhibits cytotoxic effects with IC50 values of 1.94 ± 0.09 μM for HepG2, 10.32 ± 0.39 μM for A2780, 13.1 ± 0.96 μM for HeLa, 40.69 ± 5.36 μM for HCT116, 28.11 ± 2.50 μM for SW1990, >100 μM for MCF7, and 37.42 ± 2.05 μM for L-02 cells, respectively [1]. |
| Molecular Weight | 311.31 |
| Formula | C18H14FNO3 |
| Cas No. | 2588211-50-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.